Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,967Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Polpharma

02 1Neuland Laboratories

03 3Honour Lab

04 4Dr. Reddy's Laboratories

05 1Granules India Limited

06 1Metrochem API Private Limited

07 1Cohance Lifesciences

08 1Aarti Pharmalabs

09 1Ami Lifesciences Private Limited

10 1TAPI Technology & API Services

11 1Beijing Mesochem Technology

12 1ALP Pharm

13 1Alembic Pharmaceuticals Limited

14 1Amoli Organics

15 1Aurobindo Pharma Limited

16 1Azico Biophore India Pvt. Ltd

17 1Beijing Huikang Boyuan Chemical Tech

18 1Biocon

19 1CHEMO

20 1Cipla

21 2Emnar Pharma

22 1Fuxin Long Rui Pharmaceutical

23 1Hangzhou Huadong Medicine Group Kangrun Pharmaceutical

24 1Hikal

25 1Jiangxi Synergy Pharmaceutical

26 1Laurus Labs

27 1Lee Pharma

28 1Lupin Ltd

29 2MSN Laboratories

30 1Macleods Pharmaceuticals Limited

31 1Morepen Laboratories

32 1Optimus Pharma

33 1Piramal Pharma Solutions

34 1Sichuan Kelun Pharmaceutical

35 1Sun Pharmaceutical Industries Limited

36 1USV Private Limited

37 1Viatris

38 1ZHEJIANG HONGYUAN PHARMACEUTICAL CO. - LTD

39 1ZHEJIANG LANGHUA PHARMACEUTICAL

40 2Zhejiang Huahai Pharmaceutical

41 1Zhejiang Jingsheng Pharmaceutical

42 1Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

GDUFA

DMF Review : Complete

Rev. Date : 2019-02-15

Pay. Date : 2018-10-09

DMF Number : 33180

Submission : 2018-09-27

Status : Active

Type : II

Polpharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41197

Submission : 2025-01-30

Status : Active

Type : II

Neuland

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

GDUFA

DMF Review : Complete

Rev. Date : 2017-07-05

Pay. Date : 2017-04-13

DMF Number : 31523

Submission : 2017-06-02

Status : Active

Type : II

Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32349

Submission : 2018-01-02

Status : Active

Type : II

Dr Reddy Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

GDUFA

DMF Review : Complete

Rev. Date : 2025-01-06

Pay. Date : 2024-12-26

DMF Number : 39521

Submission : 2024-03-29

Status : Active

Type : II

Granules India

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35345

Submission : 2020-10-31

Status : Active

Type : II

Metrochem

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 36944

Submission : 2022-07-12

Status : Active

Type : II

Cohance

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32379

Submission : 2017-12-21

Status : Active

Type : II

Aarti Industries Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38200

Submission : 2023-03-29

Status : Active

Type : II

AMI Lifesciences

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

GDUFA

DMF Review : Complete

Rev. Date : 2018-11-29

Pay. Date : 2018-07-27

DMF Number : 32421

Submission : 2018-09-17

Status : Active

Type : II

TAPI Company Banner

Looking for 864070-44-0 / Empagliflozin API manufacturers, exporters & distributors?

Empagliflozin manufacturers, exporters & distributors 1

46

PharmaCompass offers a list of Empagliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Empagliflozin manufacturer or Empagliflozin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Empagliflozin manufacturer or Empagliflozin supplier.

PharmaCompass also assists you with knowing the Empagliflozin API Price utilized in the formulation of products. Empagliflozin API Price is not always fixed or binding as the Empagliflozin Price is obtained through a variety of data sources. The Empagliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Empagliflozin

Synonyms

864070-44-0, Jardiance, Bi 10773, Bi-10773, Bi10773, Empagliflozin (bi 10773)

Cas Number

864070-44-0

Unique Ingredient Identifier (UNII)

HDC1R2M35U

About Empagliflozin

Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. Inhibition of SGLT2 in the kidneys also suppresses the renal reabsorption of 1,5-anhydroglucitol (1,5AG). This lowers serum 1,5AG and neutrophil 1,5-anhydroglucitol-6-phosphate (1,5AG6P) levels, which may improve neutropenia and neutrophil dysfunction in patients with glycogen storage disease type Ib (GSD Ib). SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.

EMPAGLIFLOZIN (2) Manufacturers

A EMPAGLIFLOZIN (2) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EMPAGLIFLOZIN (2), including repackagers and relabelers. The FDA regulates EMPAGLIFLOZIN (2) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EMPAGLIFLOZIN (2) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of EMPAGLIFLOZIN (2) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

EMPAGLIFLOZIN (2) Suppliers

A EMPAGLIFLOZIN (2) supplier is an individual or a company that provides EMPAGLIFLOZIN (2) active pharmaceutical ingredient (API) or EMPAGLIFLOZIN (2) finished formulations upon request. The EMPAGLIFLOZIN (2) suppliers may include EMPAGLIFLOZIN (2) API manufacturers, exporters, distributors and traders.

click here to find a list of EMPAGLIFLOZIN (2) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

EMPAGLIFLOZIN (2) USDMF

A EMPAGLIFLOZIN (2) DMF (Drug Master File) is a document detailing the whole manufacturing process of EMPAGLIFLOZIN (2) active pharmaceutical ingredient (API) in detail. Different forms of EMPAGLIFLOZIN (2) DMFs exist exist since differing nations have different regulations, such as EMPAGLIFLOZIN (2) USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A EMPAGLIFLOZIN (2) DMF submitted to regulatory agencies in the US is known as a USDMF. EMPAGLIFLOZIN (2) USDMF includes data on EMPAGLIFLOZIN (2)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The EMPAGLIFLOZIN (2) USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of EMPAGLIFLOZIN (2) suppliers with USDMF on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.